文献速递临床试验与 GCP真实世界研究与卫生经济

评估以解决方案为导向的资源取向方法(DIALOG+)改善印度和巴基斯坦精神病患者生活质量的有效性和成本效益:一项整群随机对照试验

Assessing the effectiveness and cost-effectiveness of a solution-focused resource-orientated approach (DIALOG+) to improving the quality of life for people with psychosis in India and Pakistan-a cluster RCT.
PubMed 文献 · Trials · 2023-01-26

该整群随机对照试验计划在印度金奈和巴基斯坦卡拉奇两个城市站点各纳入210例患者和14名临床医生,评估DIALOG+在社区长期精神病患者中改善生活质量和临床结局的有效性与成本效益。干预组在患者 centred 评估(DIALOG量表)基础上增加四步解决方案聚焦方法,对照组仅接受DIALOG量表评估作为主动对照。研究将评估可接受性、可行性和成本效益。

要点

  • DIALOG+是一种新型技术辅助、资源取向的干预,基于生活质量研究、以患者为中心的沟通、IT发展和解决方案聚焦治疗。
  • 该整群随机对照试验在印度和巴基斯坦两个城市站点各纳入210例患者和14名临床医生。
  • 干预组在DIALOG量表评估后增加四步解决方案聚焦方法,以识别患者资源并制定解决方案。

核心结论

  • 若被证明有效,DIALOG+有潜力改善印度和巴基斯坦数百万精神病患者的社区护理和生活质量。

研究设计与样本

  • 整群随机对照试验,在印度金奈和巴基斯坦卡拉奇两个城市站点各纳入210例患者和14名临床医生。
  • 干预在临床医生与患者的常规互动中使用,对照组接受以患者为中心的DIALOG量表评估作为主动对照,干预组在此基础上增加四步解决方案聚焦方法。

主要发现

  • 该研究旨在评估DIALOG+改善社区长期精神病患者生活质量和临床结局的有效性与成本效益,并评估其可接受性、可行性和成本效益。
  • DIALOG+此前尚未在印度和巴基斯坦进行严格测试。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe mental illness (SMI) presents a major challenge worldwide, affecting approximately 5-8% of the world's population. It causes significant distress to affected people, families and wider communities, generating high costs through loss of productivity and ongoing healthcare use. Over 75% of patients with psychosis receive inadequate care and experience a negative financial impact and reduced quality of life (QoL). It is therefore a priority to reduce the treatment gap by providing low-cost, effective interventions for people with psychosis. Our research project, PIECEs, is designed to explore, adapt and test a low-cost, approach (DIALOG+) that makes use of existing resources to improve community-based care for patients with psychosis. The research will be conducted in two urban sites: Karachi, Pakistan and Chennai, India. DIALOG+ is a novel, technology-assisted and resource-oriented intervention, based on QoL research, concepts of patient-centred communication, IT developments and solution-focused therapy. However, the approach has not been rigorously tested within India and Pakistan. Our randomised controlled trial (RCT) aims to test the effectiveness and cost-effectiveness of DIALOG+ in improving the QoL and clinical outcomes for individuals with long-term psychosis being treated in the community in India and Pakistan. METHODS: To assess the acceptability, feasibility, and cost effectiveness of DIALOG+, we will conduct a cluster RCT with 210 patients and 14 clinicians in each country. The intervention will be used during a routine interaction between a clinician and a patient. It consists of a patient-centred assessment (the DIALOG scale) whereby the clinician invites the patient to rate their satisfaction with different life domains and treatment aspects, which forms the active control group. The intervention group will follow this up with a four-step solution-focused approach to identify the patient's resources and develop solutions to deal with the patient's concerns (DIALOG+). DISCUSSION: If shown to be effective DIALOG+ has the potential to improve community-based care and the QoL for millions of people within India and Pakistan who experience psychosis. TRIAL REGISTRATION: The trial was registered prospectively on the ISRCTN Registry: ISRCTN13022816 on 9 February 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bird VJ, Sajun SZ, Peppl R, et al. Assessing the effectiveness and cost-effectiveness of a solution-focused resource-orientated approach (DIALOG+) to improving the quality of life for people with psychosis in India and Pakistan-a cluster RCT. Trials. 2023. PMID: 36703162. doi:10.1186/s13063-022-07032-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。